Internal Medicine, Medical Oncology · Norton Shores, MI
NPI
1568468882
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6425 S Harvey St, Suite 200
Norton Shores, MI, 49444
Phone (231) 737-3469
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
121,660 services
Medicare patients, 2024
535
Average age 73
Drug cost, 2024
$9.7M
3,672 prescriptions
Company payments, 2025
$665
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn B Alguire was code J1442 (injection, filgrastim (g-csf), excludes biosimilars, 1 microgram), 17,460 times for 13 patients. In total Kathryn B Alguire billed 121,660 services in 184 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1442 Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | Office | 17,460 | 13 | $0.78 | $14K |
| J9267 Injection, paclitaxel, 1 mg | Office | 9,120 | 13 | $0.08 | $738 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,896 | 44 | $0.09 | $169 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,740 | 13 | $35.76 | $62K |
| 36415 Venipuncture Blood Collection | Office | 740 | 197 | $8.61 | $6,369 |
| 85025 Blood Count | Office | 693 | 157 | $7.58 | $5,255 |
| 80053 Clinical Chemistry | Office | 604 | 150 | $10.21 | $6,164 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 600 | 17 | $0.66 | $398 |
| J9045 Injection, carboplatin, 50 mg | Office | 502 | 19 | $2.81 | $1,411 |
| 96375 Injection Administration | Office | 442 | 60 | $10.72 | $4,738 |
| 99213 Office E&M - Established | Office | 416 | 267 | $57.13 | $24K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 352 | 12 | $0.23 | $80.06 |
| 96413 Chemotherapy Administration | Office | 278 | 68 | $89.22 | $25K |
| 99214 Office E&M - Established | Office | 220 | 101 | $92.80 | $20K |
| J3489 Injection, zoledronic acid, 1 mg | Office | 194 | 29 | $4.60 | $893 |
By year: 2022 $2.9M for 151,470 services; 2023 $2.3M for 158,782 services; 2024 $1.9M for 121,660 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 740 | 197 | $8.61 | $6,369 |
| 85025 Blood Count | 693 | 157 | $7.58 | $5,255 |
| 80053 Clinical Chemistry | 604 | 150 | $10.21 | $6,164 |
| 83735 Clinical Chemistry | 154 | 37 | $6.46 | $995 |
| 82784 Immunoassay | 117 | 14 | $9.11 | $1,066 |
| 86300 Immunoassay | 55 | 20 | $20.39 | $1,121 |
| 82728 Clinical Chemistry | 54 | 33 | $13.36 | $721 |
| 83615 Clinical Chemistry | 44 | 26 | $5.92 | $260 |
| 84443 Clinical Chemistry | 44 | 15 | $16.46 | $724 |
| 82565 Clinical Chemistry | 38 | 27 | $5.02 | $191 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn B Alguire prescribed most often to Medicare patients was Anastrozole, with 1,223 prescriptions and refills. In total Kathryn B Alguire wrote 3,672 Medicare prescriptions that cost $9.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 1,223 | 3,383 | 398 | $43K |
| Exemestane Generic | 246 | 575 | 73 | $41K |
| Letrozole Generic | 169 | 431 | 50 | $4,383 |
| Prochlorperazine Maleate Generic | 135 | 135 | 68 | $2,067 |
| Acyclovir Generic | 124 | 166 | 23 | $1,309 |
| Ibrance Palbociclib | 124 | 124 | 14 | $1.9M |
| Tamoxifen Citrate Generic | 109 | 303 | 37 | $3,987 |
| Alendronate Sodium Generic | 103 | 252 | 30 | $1,201 |
| Imbruvica Ibrutinib | 72 | 72 | Under 11 | $954K |
| Lenalidomide Generic | 65 | 65 | Under 11 | $982K |
| Hydroxyurea Generic | 63 | 135 | 13 | $1,950 |
| Verzenio Abemaciclib | 62 | 62 | Under 11 | $855K |
| Ondansetron Odt Ondansetron | 61 | 61 | 26 | $647 |
| Olanzapine Generic | 58 | 61 | 40 | $374 |
| Dexamethasone Generic | 56 | 66 | 26 | $609 |
Brand drugs: - claims; generic drugs: 2,852 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn B Alguire $665 ($665 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $182.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $182 |
| Merck Sharp & Dohme LLC MRK | 4 | $121 |
| SpringWorks Therapeutics, Inc. | 4 | $88.92 |
| Genzyme Corporation SNY | 3 | $63.28 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $40.2 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $39.56 |
| BeiGene USA, Inc. ONC | 1 | $29.53 |
| Abbvie Inc. ABBV | 1 | $24.98 |
| Array Biopharma Inc PFE | 1 | $23.77 |
| Puma Biotechnology, Inc. PBYI | 1 | $19.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.